liquid biopsy technology

Harnessing Liquid Biopsies in Clinical Trials

Liquid biopsy technology is emerging as an enormously promising tool in the fight against cancer. Because it can detect changes in tumor genetics well before imaging reveals changes in growth, it has the potential to enable earlier intervention or treatment … Read More

immunotherapy clinical trials

Answering Your Toughest Immunotherapy Clinical Trials Questions

Small to midsize biopharmaceutical companies play significant, pioneering roles in innovating novel cancer therapeutics, particularly with the new wave of immunotherapeutic agents. They also have plenty of questions about clinical trial hurdles unique to this class of drugs — one … Read More

Oncology CRO

Novella Clinical Executive Named to PharmaVOICE 100

Since 2005, PharmaVOICE has honored innovative scientists through its PharmaVOICE 100. Scientists are selected for their contributions to the life sciences industry, specifically, their leadership, management, knowledge, and willingness to tackle major industry challenges – and the inspiration they bring. This … Read More

European Accelerated Regulatory Pathways Show Momentum

The European Medicines Agency (EMA) has launched a new expedited approval pathway similar to those available in the US to facilitate access to medicines for patients in the European Union (EU). European regulators introduced the PRIority MEdicines (PRIME) approval pathway … Read More

Physician Spotlight

Dr. Leslie Clapp: Excellence in Clinical Research and Guidance

For more than 25 years, Leslie Clapp, M.D., F.A.A.P., has excelled in her career, as a pediatrician, and now as Novella Clinical’s Executive Medical Director, responsible for helping ensure the safety of patients during clinical trials. In addition to academic honors, … Read More

Clinical Trials: Need for Education & Participation

Novella’s Columbus office recently had the pleasure of hosting a discussion about oncology clinical trial participation. Our staff heard directly from oncology trial sites, patient advocacy groups and cancer patients about their experiences in oncology clinical trials. Incidence & Outlook … Read More

CRISPR-Cas9 Oncology

Harnessing CRISPR-Cas9 within Oncology Clinical Research

CRISPR-Cas9 is a breakthrough gene-editing technology that is radically simpler, cheaper and more potent than its predecessors, thus arming researchers with a powerful tool in their fight against cancer. The uses for the technology range widely from screening for potential … Read More